The challenges of oral agents as antineoplastic treatments.
The challenges of oral agents as antineoplastic treatments.
复制标题
DOI：
10.1016/j.soncn.2011.02.003
复制
发表时间：
2011-05-01
影响因子：
2.2
通讯作者：
Grant, Marcia
中科院分区：
文献类型：
--
作者：
Given, Barbara A;Spoelstra, Sandra L;Grant, Marcia
目的：鉴于在癌症管理中越来越多地使用口服抗肿瘤药物，患者依从性对成功的治疗结果至关重要。本文回顾了问题的范围和问题的坚持口服pharmacologes.DATA来源：研究为基础的和其他文章，通讯，和conference presentations.CONCLUSION：次优坚持口服pharmacologes.Suboptimal是一个重要的临床问题，可能会导致疾病或治疗并发症，调整治疗方案，疾病进展，和过早死亡。医疗保健提供者需要通过识别障碍和实施策略来监测和促进依从性，以确保依从性，从而改善临床结果。
OBJECTIVES: Given the increasing use of oral antineoplastic agents in cancer management, patient adherence is critical to successful treatment outcomes. This article reviews the scope of the problem and issues of adherence to oral antineoplastic agents.DATA SOURCES: Research-based and other articles, newsletters, and conference presentations.CONCLUSION: Suboptimal adherence to oral antineoplastic agents is a significant clinical problem that may result in disease or treatment complications, adjustment in treatment regimen, disease progression, and premature death.IMPLICATIONS FOR NURSING PRACTICE: Healthcare providers need to monitor and facilitate adherence by identifying barriers and implementing strategies to assure adherence, and therefore, improve clinical outcomes.